Using LabPiQture to Uncover or Rule Out Chronic Kidney Disease
Chronic kidney disease (CKD) affects an estimated 35.5 million people in the United States, and the number of individuals progressing to kidney failure continues to rise. As this public health challenge grows, insurers face an essential question: How can we efficiently and confidently determine whether an applicant shows signs of kidney disease?
In a recent case study, ExamOne demonstrated how LabPiQture™—a comprehensive laboratory data solution—can reveal or disprove the presence of CKD by highlighting key eGFR (estimated Glomerular Filtration Rate) results.
Understanding eGFR
According to the National Kidney Foundation, glomerular filtration rate (GFR) is the most reliable measure of kidney function. Healthcare providers use the estimated GFR (eGFR)—calculated from a simple blood test—to determine whether kidney disease is present and, if so, to classify its stage.
eGFR provides a clear, quantifiable picture of how well the kidneys are filtering waste from the blood, making it an invaluable marker in both clinical and underwriting settings.
Why eGFR Matters to Underwriters
For underwriters, eGFR results can help assess the stability or instability of kidney function over time.
Patterns in eGFR values may indicate chronic disease progression, recovery, or even data inconsistencies, all of which influence risk assessment. With this information, underwriters can make more informed and confident decisions—faster than ever before.
Accessing eGFR Data with LabPiQture
Through ExamOne’s LabPiQture, underwriters gain access to clinically ordered laboratory testing results, including detailed eGFR data. The results are clearly highlighted within the LabPiQture interface, allowing underwriters to identify kidney-related risk factors quickly and efficiently.
To see how eGFR results play a critical role in assessing CKD risk, explore the case study that illustrates LabPiQture in action.
About LabPiQture
LabPiQture™ gives insurers access to one of the most comprehensive clinical laboratory databases available today—covering tests ordered by healthcare professionals for preventive care, diagnostic evaluation, and ongoing disease monitoring.
This powerful data source has become an integral part of modern underwriting decisions. In addition to raw test results, LabPiQture includes valuable context such as diagnosis codes, LOINC codes, and ordering physician information, enabling a more holistic understanding of each applicant’s health profile.
Reinsurers are increasingly studying de-identified LabPiQture datasets to measure the predictive strength and underwriting value of this unique information. Their findings consistently reinforce one conclusion: clinical lab data provides a deeper, more reliable picture of an applicant’s health than traditional sources alone.
Learn more about how LabPiQture helps insurers uncover critical CKD insights—and empowers smarter, faster, and fairer underwriting decisions.